These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33814345)

  • 1. The muscle-relaxing C-terminal peptide from troponin I populates a nascent helix, facilitating binding to tropomyosin with a potent therapeutic effect.
    Hornos F; Feng HZ; Rizzuti B; Palomino-Schätzlein M; Wieczorek D; Neira JL; Jin JP
    J Biol Chem; 2021; 296():100228. PubMed ID: 33814345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolutionarily conserved C-terminal peptide of troponin I is an independently configured regulatory structure to function as a myofilament Ca
    Wong S; Feng HZ; Jin JP
    J Mol Cell Cardiol; 2019 Nov; 136():42-52. PubMed ID: 31505197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
    Gomes AV; Harada K; Potter JD
    J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-terminal troponin-I residues trap tropomyosin in the muscle thin filament blocked-state.
    Lehman W; Pavadai E; Rynkiewicz MJ
    Biochem Biophys Res Commun; 2021 Apr; 551():27-32. PubMed ID: 33714756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy.
    Lang R; Gomes AV; Zhao J; Housmans PR; Miller T; Potter JD
    J Biol Chem; 2002 Apr; 277(14):11670-8. PubMed ID: 11801593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-regulated conformational change in the C-terminal end segment of troponin I and its binding to tropomyosin.
    Zhang Z; Akhter S; Mottl S; Jin JP
    FEBS J; 2011 Sep; 278(18):3348-59. PubMed ID: 21777381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils.
    Iorga B; Blaudeck N; Solzin J; Neulen A; Stehle I; Lopez Davila AJ; Pfitzer G; Stehle R
    Cardiovasc Res; 2008 Mar; 77(4):676-86. PubMed ID: 18096573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
    Alves ML; Dias FAL; Gaffin RD; Simon JN; Montminy EM; Biesiadecki BJ; Hinken AC; Warren CM; Utter MS; Davis RT; Sakthivel S; Robbins J; Wieczorek DF; Solaro RJ; Wolska BM
    Circ Cardiovasc Genet; 2014 Apr; 7(2):132-143. PubMed ID: 24585742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice.
    Wen Y; Pinto JR; Gomes AV; Xu Y; Wang Y; Wang Y; Potter JD; Kerrick WG
    J Biol Chem; 2008 Jul; 283(29):20484-94. PubMed ID: 18430738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the dynamics of the cardiac troponin C molecule explain the effects of Ca
    Stevens CM; Rayani K; Singh G; Lotfalisalmasi B; Tieleman DP; Tibbits GF
    J Biol Chem; 2017 Jul; 292(28):11915-11926. PubMed ID: 28533433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy.
    Takahashi-Yanaga F; Morimoto S; Harada K; Minakami R; Shiraishi F; Ohta M; Lu QW; Sasaguri T; Ohtsuki I
    J Mol Cell Cardiol; 2001 Dec; 33(12):2095-107. PubMed ID: 11735257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relaxation Properties of Myofibrils Are Compromised by Amino Acids that Stabilize α-Tropomyosin.
    Scellini B; Piroddi N; Matyushenko AM; Levitsky DI; Poggesi C; Lehrer SS; Tesi C
    Biophys J; 2017 Jan; 112(2):376-387. PubMed ID: 28122223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional studies on Troponin I and Troponin C interactions.
    Ngai SM; Pearlstone JR; Farah CS; Reinach FC; Smillie LB; Hodges RS
    J Cell Biochem; 2001 Jun 26-Jul 25; 83(1):33-46. PubMed ID: 11500952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic mapping of regions of human cardiac troponin I involved in binding to cardiac troponin C: N- and C-terminal low affinity contributing regions.
    Ferrières G; Pugnière M; Mani JC; Villard S; Laprade M; Doutre P; Pau B; Granier C
    FEBS Lett; 2000 Aug; 479(3):99-105. PubMed ID: 10981715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca2+-dependent photocrosslinking of tropomyosin residue 146 to residues 157-163 in the C-terminal domain of troponin I in reconstituted skeletal muscle thin filaments.
    Mudalige WA; Tao TC; Lehrer SS
    J Mol Biol; 2009 Jun; 389(3):575-83. PubMed ID: 19379756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy mutations increase myofilament Ca
    Robinson P; Liu X; Sparrow A; Patel S; Zhang YH; Casadei B; Watkins H; Redwood C
    J Biol Chem; 2018 Jul; 293(27):10487-10499. PubMed ID: 29760186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced troponin I binding explains the functional changes produced by the hypertrophic cardiomyopathy mutation A8V of cardiac troponin C.
    Zot HG; Hasbun JE; Michell CA; Landim-Vieira M; Pinto JR
    Arch Biochem Biophys; 2016 Jul; 601():97-104. PubMed ID: 26976709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the NH(2)- and COOH-terminal domains of the inhibitory region of troponin I in the regulation of skeletal muscle contraction.
    Szczesna D; Zhang R; Zhao J; Jones M; Potter JD
    J Biol Chem; 1999 Oct; 274(41):29536-42. PubMed ID: 10506219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the mutation R145G in human cardiac troponin I on the kinetics of the contraction-relaxation cycle in isolated cardiac myofibrils.
    Kruger M; Zittrich S; Redwood C; Blaudeck N; James J; Robbins J; Pfitzer G; Stehle R
    J Physiol; 2005 Apr; 564(Pt 2):347-57. PubMed ID: 15718266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restrictive cardiomyopathy mutations demonstrate functions of the C-terminal end-segment of troponin I.
    Akhter S; Bueltmann K; Huang X; Jin JP
    Arch Biochem Biophys; 2014 Jun; 552-553():3-10. PubMed ID: 24326031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.